Atlas Trials

Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027)

Clinical trial NCT00944450 · COMPLETED

Trial details

NCT number
NCT00944450
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2004-08-01
Primary completion
2004-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.